NCT01537614View on ClinicalTrials.gov

Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 28, 2013

Conditions
Cystic Fibrosis
Interventions
DRUG

COLIMYCINE inhalation

2 MILLION UI

DRUG

COLIMYCINE injectable

2 MILLIONS UI

Trial Locations (1)

86021

Poitiers University Hospital, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT01537614 - Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis | Biotech Hunter | Biotech Hunter